NDC Compounded Drug 72682-3315-1 Edetate Disodium
Injection Intravenous
Compounded Drug Product Information
NDC Crossover Products Matching Edetate Disodium
NDC crossover of Edetate Disodium (pf) 150mg/ml 10ml with NDC 72682-3315 a human compounded drug with other similar products matching the same substance name (Edetate Disodium) and the same administration route (intravenous) or dosage form (injection).
| NDC | Proprietary Name | Non-Proprietary Name | Package Desc | Dosage Form | Route Name | Company Name |
|---|---|---|---|---|---|---|
| 26436-5023-5 | Disodium Edetate 150mg/ml | Disodium Edetate 150mg/ml | 50 mL in 1 VIAL, MULTI-DOSE | Injection | Intramuscular; Intravenous | Hybrid Pharma |
| 26436-5023-5 | Disodium Edetate 150mg/ml | Disodium Edetate 150mg/ml | 50 mL in 1 VIAL, MULTI-DOSE | Injection | Intramuscular; Intravenous | Hybrid Pharma |
| 72627-2401-1 | Edetate Disodium | Edetate Disodium | 30 mL in 1 VIAL, SINGLE-DOSE | Injection | Intravenous | Empower Pharmacy |
Frequently Asked Questions
What is the NDC number assigned to Edetate Disodium?
Edetate Disodium was assigned by its manufacturer with NDC product code 72682-3315. This product is a drug classified as a human compounded drug. Compounded drugs are medications created by combining or altering existing drugs to meet the specific needs of certain patients. The NDC directory only includes information about compounded drugs from facilities that choose to assign NDC numbers to their products.
Which are the NDC package codes for Edetate Disodium?
The NDC package code 72682-3315-1 was assigned to a 10 mL in 1 VIAL of edetate disodium administered intravenous via injection.
Who manufactures this product?
Edetate Disodium is manufactured by an outsourced facility and labeled by Anazaohealth Corporation. All compounded drugs included in the NDC directory are classified as "Outsourcing Facility Compounded Human Drug Product (Exempt from Approval Requirements)". Outsourcing facilities are a type of drug compounding facility regulated under Section 503B of the FD&C Act could be eligible for exemptions from drug registration if they meet all the conditions specified under Section 503B.
Which are the NDC crossover matchings for this product?
We found 3 matching products that have the same substance, dosage form and administration route. The matching products are manufactured by Hybrid Pharma and Empower Pharmacy with NDC product codes 26436-5023-5, 26436-5023-5 and 72627-2401-1.